Market closed

Arcellx/$ACLX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Arcellx

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Ticker

$ACLX
Trading on

Industry

Biotechnology

Employees

163

Arcellx Metrics

BasicAdvanced
$3.7B
-
-$2.00
0.32
-
$3.7B
0.32
$107.37
$47.88
679K
4.779
4.684
10.234
11.891
-133.56%
-11.19%
-22.84%
33.365
8.03
8.03
-37.164
-2.16%
36.25%
-76.03%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ACLX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Arcellx stock?

Arcellx (ACLX) has a market cap of $3.7B as of April 04, 2025.

What is the P/E ratio for Arcellx stock?

The price to earnings (P/E) ratio for Arcellx (ACLX) stock is 0 as of April 04, 2025.

Does Arcellx stock pay dividends?

No, Arcellx (ACLX) stock does not pay dividends to its shareholders as of April 04, 2025.

When is the next Arcellx dividend payment date?

Arcellx (ACLX) stock does not pay dividends to its shareholders.

What is the beta indicator for Arcellx?

Arcellx (ACLX) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.